| |
 |
INTRODUCTION
BIOMEDICUM
BIOCHIP CENTER
(BBC) is a research unit and core facility at the Biomedicum Helsinki. Biochip
Center focuses on the development of biochip technologies for post-genomic
era biomedical research. These include high-throughput screening of the
genome, transcriptome and proteome coupled with cell-based functional
screening. The center is also developing bioinformatics-based analyses of
biochip data, and applying these capabilities in research of diseases, such
as cancer and complex diseases. BBC is focused on research and
technology development, but also functions as a core facility providing
microarray services for academic and commercial customers.
Currently, our standard service products include biochips for genome-wide gene expression, miRNA expression, copy number profiling, and
ChIP-on-chip (including e.g. RNA/DNA extraction, RNA quality
assessment). We have further expanded our services to other functional genomics technologies including gene silencing by lentiviral mediated RNAi. For more information about our biochip and virus services, please visit Biomedicum Genomics.
The
“mission” of BBC
1. Biochip technology development
including SNP, CGH, oligo, and lysate microarrays.
2. Application of the biochips in identification of novel drug targets for
cancer.
3. Development of novel bioinformatics tools for the analysis of microarray
data.
4. Application of microarrays in the study of complex diseases.
5. Operation as a core facility to offer microarray services for academic and
commercial users. |
|
|
 |
